SCHEMBL206929

SCHEMBL206929

[c]1cccc2c1Oc1ccccc1O2

nearest known ligand 0.37

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
AHR P35869 3/20 0.37
MAOA P21397 2/20 0.36
MAOB P27338 2/20 0.36
ALOX5 P09917 1/20 0.36
TRPA1 O75762 1/20 0.30
KDM4E B2RXH2 1/20 0.30
MAPK1 P28482 1/20 0.30
ATM Q13315 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3292005 0.93
SCHEMBL5728873 0.77 AHR (0.32) AHR
SCHEMBL2749118 0.73 MAOA (0.59) MAOAMAOB
SCHEMBL132889 0.73 ATM (0.31) MAOAATM
SCHEMBL25006 0.73 ALOX5 (0.59) ALOX5KDM4E
SCHEMBL125113 0.72 MAOA (0.56) AHRMAOAMAOBALOX5TRPA1
SCHEMBL29383458 0.72 MAOA (0.56) AHRMAOAMAOBALOX5TRPA1
SCHEMBL3102452 0.72 MAOA (0.56) AHRMAOAMAOBALOX5TRPA1
SCHEMBL29724179 0.72 MAOA (0.56) AHRMAOAMAOBALOX5TRPA1
SCHEMBL8668546 0.72 MAOA (0.56) AHRMAOAMAOBALOX5TRPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 547 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4399200-A1 (HET)ARYL SUBSTITUTED BISPHENOL COMPOUNDS AND THERMOPLASTIC RESINS Mitsubishi Gas Chemical Company, Inc. (JP) 2024-07-17 EP claimed
EP-4399199-A1 (HET)ARYL SUBSTITUTED BISPHENOL COMPOUNDS AND THERMOPLASTIC RESINS Reuter Chemische Apparatebau e.K. (DE) 2024-07-17 EP claimed
CN-110277500-B Organic light emitting device 三星显示有限公司 2024-06-21 CN claimed
CN-118043298-A (Hetero) aryl-substituted bisphenol compound and thermoplastic resin 罗伊特化学仪器制造公司 2024-05-14 CN claimed
US-11952460-B2 Polycarbonate resin, method for producing the same, and optical lens MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2024-04-09 US claimed
US-11944003-B2 Organic light-emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2024-03-26 US claimed
US-20230391704-A1 TRIARYLMETHANE COMPOUNDS MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2023-12-07 US claimed
WO-2023179094-A1 ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE COMPRISING SAME 北京莱特众成光电材料科技有限公司 2023-09-28 WO claimed
CN-113754641-B Organic compound, and electronic element and electronic device using same 陕西莱特光电材料股份有限公司 2023-06-23 CN claimed
US-20230192668-A1 ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE THEREOF SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-06-22 US claimed
WO-2004106356-A1 FUNCTIONALIZED NUCLEOTIDE DERIVATIVES SYDDANSK UNIVERSITET (DK) 2004-12-09 WO claimed
US-6498190-B1 TREATMENT OF NASAL OCCLUSION AND MAST CELL DYSFUNCTION DISEASES; ANTIINFLAMMATORY AGENTS SHIONOGI & CO., LTD. (JP) 2002-12-24 US claimed
EP-0837052-A1 BICYCLIC AMINO DERIVATIVES AND PGD 2 ANTAGONIST CONTAINING THE SAME SHIONOGI & CO., LTD. (JP) 1998-04-22 EP claimed
US-4618686-A INCLUDES POLYCHLORINATED BIPHENYLS AND DIBENZO-P-DIOXINS; PALLADIUM CATALYST AND PHYPOPHOSPHITE CIBA-GEIGY CORPORATION (US) 1986-10-21 US claimed
US-4140681-A ANTICOAGULANTS MITSUBISHI CHEMICAL INDUSTRIES, LIMITED (JP) 1979-02-20 US claimed
US-4131673-A INHIBITION AND SUPPRESSION OF THROMBOSIS IN MAMMALS MITSUBISHI CHEMICAL INDUSTRIES, LIMITED (JP) 1978-12-26 US claimed
US-4125604-A PEPTIDES, ANTITHROMBOSIS MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) 1978-11-14 US claimed
US-4101653-A ANTITHROMBOSIS MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) 1978-07-18 US claimed
US-4093712-A ANTITHROMBOGENIC AGENTS MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JA) 1978-06-06 US claimed
US-4066773-A ANTITHROMBOSIS MITSUBISHI CHEMICAL INDUSTRIES LTD. (JA) 1978-01-03 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230192668-A1 ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE THEREOF XPO4, OR10J3, EPB41 AHR 1253/4885MAOA 1787/4885MAOB 996/4885
US-20230391704-A1 TRIARYLMETHANE COMPOUNDS CBR3, HAX1, HRH3 AHR 13/4885MAOA 3067/4885MAOB 3531/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.